146 related articles for article (PubMed ID: 29701260)
1. C-reactive protein: An independent predictor for dedifferentiated chondrosarcoma.
Nemecek E; Funovics PT; Hobusch GM; Lang S; Willegger M; Sevelda F; Brodowicz T; Stihsen C; Windhager R; Panotopoulos J
J Orthop Res; 2018 Oct; 36(10):2797-2801. PubMed ID: 29701260
[TBL] [Abstract][Full Text] [Related]
2. Dedifferentiated chondrosarcoma: A survival analysis of 159 cases from the SEER database (2001-2011).
Strotman PK; Reif TJ; Kliethermes SA; Sandhu JK; Nystrom LM
J Surg Oncol; 2017 Aug; 116(2):252-257. PubMed ID: 28420036
[TBL] [Abstract][Full Text] [Related]
3. Survival and Prognosis of Chondrosarcoma Subtypes: SEER Database Analysis.
Amer KM; Munn M; Congiusta D; Abraham JA; Basu Mallick A
J Orthop Res; 2020 Feb; 38(2):311-319. PubMed ID: 31498474
[TBL] [Abstract][Full Text] [Related]
4. Dedifferentiated chondrosarcoma: the role of chemotherapy with updated outcomes.
Dickey ID; Rose PS; Fuchs B; Wold LE; Okuno SH; Sim FH; Scully SP
J Bone Joint Surg Am; 2004 Nov; 86(11):2412-8. PubMed ID: 15523011
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of the serum level of C-reactive protein for the survival of patients with a primary sarcoma of bone.
Nakamura T; Grimer RJ; Gaston CL; Watanuki M; Sudo A; Jeys L
Bone Joint J; 2013 Mar; 95-B(3):411-8. PubMed ID: 23450030
[TBL] [Abstract][Full Text] [Related]
6. Does ifosfamide therapy improve survival of patients with dedifferentiated chondrosarcoma?
Kawaguchi S; Sun T; Lin PP; Deavers M; Harun N; Lewis VO
Clin Orthop Relat Res; 2014 Mar; 472(3):983-9. PubMed ID: 24197392
[TBL] [Abstract][Full Text] [Related]
7. Hemoglobin, alkalic phosphatase, and C-reactive protein predict the outcome in patients with liposarcoma.
Panotopoulos J; Posch F; Alici B; Funovics P; Stihsen C; Amann G; Brodowicz T; Windhager R; Ay C
J Orthop Res; 2015 May; 33(5):765-70. PubMed ID: 25641201
[TBL] [Abstract][Full Text] [Related]
8. Is Chemotherapy Associated with Improved Overall Survival in Patients with Dedifferentiated Chondrosarcoma? A SEER Database Analysis.
Cranmer LD; Chau B; Mantilla JG; Loggers ET; Pollack SM; Kim TS; Kim EY; Kane GM; Thompson MJ; Harwood JL; Wagner MJ
Clin Orthop Relat Res; 2022 Apr; 480(4):748-758. PubMed ID: 34648466
[TBL] [Abstract][Full Text] [Related]
9. Can Machine-learning Techniques Be Used for 5-year Survival Prediction of Patients With Chondrosarcoma?
Thio QCBS; Karhade AV; Ogink PT; Raskin KA; De Amorim Bernstein K; Lozano Calderon SA; Schwab JH
Clin Orthop Relat Res; 2018 Oct; 476(10):2040-2048. PubMed ID: 30179954
[TBL] [Abstract][Full Text] [Related]
10. Conventional Primary Central Chondrosarcoma of the Pelvis: Prognostic Factors and Outcome of Surgical Treatment in 162 Patients.
Bus MPA; Campanacci DA; Albergo JI; Leithner A; van de Sande MAJ; Gaston CL; Caff G; Mettelsiefen J; Capanna R; Tunn PU; Jeys LM; Dijkstra PDS
J Bone Joint Surg Am; 2018 Feb; 100(4):316-325. PubMed ID: 29462035
[TBL] [Abstract][Full Text] [Related]
11. Serum creatinine and albumin predict sarcoma-specific survival in patients with myofibroblastic and fibroblastic sarcomas.
Willegger M; Posch F; Schieder S; Funovics PT; Scharrer A; Brodowicz T; Ay C; Windhager R; Panotopoulos J
J Orthop Res; 2017 Dec; 35(12):2815-2824. PubMed ID: 28485477
[TBL] [Abstract][Full Text] [Related]
12. Dedifferentiated chondrosarcoma: prognostic factors and outcome from a European group.
Grimer RJ; Gosheger G; Taminiau A; Biau D; Matejovsky Z; Kollender Y; San-Julian M; Gherlinzoni F; Ferrari C
Eur J Cancer; 2007 Sep; 43(14):2060-5. PubMed ID: 17720491
[TBL] [Abstract][Full Text] [Related]
13. Primary Tumor Resection Prolongs Survival in Spinal Chondrosarcoma Patients With Distant Metastasis.
Song K; Lin K; Kang H; Dong Y; Guan H; Li F
Spine (Phila Pa 1976); 2020 Dec; 45(24):E1661-E1668. PubMed ID: 32925686
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer.
Liu Y; Chen S; Zheng C; Ding M; Zhang L; Wang L; Xie M; Zhou J
BMC Cancer; 2017 Apr; 17(1):285. PubMed ID: 28431566
[TBL] [Abstract][Full Text] [Related]
15. Dedifferentiated chondrosarcoma revisited.
Mavrogenis AF; Ruggieri P; Mercuri M; Papagelopoulos PJ
J Surg Orthop Adv; 2011; 20(2):106-11. PubMed ID: 21838071
[TBL] [Abstract][Full Text] [Related]
16. The clinical pathological significance of FRAT1 and ROR2 expression in cartilage tumors.
He L; Yang Z; Zhou J; Wang W
Clin Transl Oncol; 2015 Jun; 17(6):438-45. PubMed ID: 25387569
[TBL] [Abstract][Full Text] [Related]
17. Single determination of C-reactive protein at the time of diagnosis predicts long-term outcome of patients with hepatocellular carcinoma.
Sieghart W; Pinter M; Hucke F; Graziadei I; Schöniger-Hekele M; Müller C; Vogel W; Trauner M; Peck-Radosavljevic M
Hepatology; 2013 Jun; 57(6):2224-34. PubMed ID: 22961713
[TBL] [Abstract][Full Text] [Related]
18. Digital PCR analysis of circulating tumor DNA: a biomarker for chondrosarcoma diagnosis, prognostication, and residual disease detection.
Gutteridge A; Rathbone VM; Gibbons R; Bi M; Archard N; Davies KEJ; Brown J; Plagnol V; Pillay N; Amary F; O'Donnell P; Gupta M; Tirabosco R; Flanagan AM; Forshew T
Cancer Med; 2017 Oct; 6(10):2194-2202. PubMed ID: 28834325
[TBL] [Abstract][Full Text] [Related]
19. Management and prognostic significance of pathological fractures through chondrosarcoma of the femur.
Albergo JI; Gaston CL; Jeys LM; Khajuria A; Carter SR; Tillman RM; Abudu AT; Grimer RJ
Int Orthop; 2015 May; 39(5):943-6. PubMed ID: 25711397
[TBL] [Abstract][Full Text] [Related]
20. Serum C-reactive protein and overall survival of patients with osteosarcoma.
Li X; Tian F; Wang F; Li Y
Tumour Biol; 2015 Jul; 36(7):5663-6. PubMed ID: 25986475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
